1. Home
  2. KVYO vs DVA Comparison

KVYO vs DVA Comparison

Compare KVYO & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KVYO
  • DVA
  • Stock Information
  • Founded
  • KVYO 2012
  • DVA 1994
  • Country
  • KVYO United States
  • DVA United States
  • Employees
  • KVYO N/A
  • DVA N/A
  • Industry
  • KVYO
  • DVA Misc Health and Biotechnology Services
  • Sector
  • KVYO
  • DVA Health Care
  • Exchange
  • KVYO Nasdaq
  • DVA Nasdaq
  • Market Cap
  • KVYO 10.1B
  • DVA 10.9B
  • IPO Year
  • KVYO 2023
  • DVA 1995
  • Fundamental
  • Price
  • KVYO $32.02
  • DVA $136.95
  • Analyst Decision
  • KVYO Buy
  • DVA Hold
  • Analyst Count
  • KVYO 21
  • DVA 4
  • Target Price
  • KVYO $43.05
  • DVA $157.00
  • AVG Volume (30 Days)
  • KVYO 1.9M
  • DVA 736.8K
  • Earning Date
  • KVYO 08-06-2025
  • DVA 08-05-2025
  • Dividend Yield
  • KVYO N/A
  • DVA N/A
  • EPS Growth
  • KVYO N/A
  • DVA 14.90
  • EPS
  • KVYO N/A
  • DVA 10.11
  • Revenue
  • KVYO $1,007,298,000.00
  • DVA $12,968,524,000.00
  • Revenue This Year
  • KVYO $27.79
  • DVA $6.46
  • Revenue Next Year
  • KVYO $20.95
  • DVA $3.24
  • P/E Ratio
  • KVYO N/A
  • DVA $13.41
  • Revenue Growth
  • KVYO 33.95
  • DVA 5.11
  • 52 Week Low
  • KVYO $21.26
  • DVA $131.76
  • 52 Week High
  • KVYO $49.55
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • KVYO 41.45
  • DVA 44.92
  • Support Level
  • KVYO $33.11
  • DVA $134.64
  • Resistance Level
  • KVYO $34.93
  • DVA $138.26
  • Average True Range (ATR)
  • KVYO 1.25
  • DVA 2.71
  • MACD
  • KVYO -0.25
  • DVA 0.14
  • Stochastic Oscillator
  • KVYO 3.45
  • DVA 54.56

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

Share on Social Networks: